Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections

Antimicrob Agents Chemother. 2004 Feb;48(2):677-80. doi: 10.1128/AAC.48.2.677-680.2004.

Abstract

We studied the telithromycin, erythromycin, azithromycin, and clindamycin susceptibilities of serotype III macrolide-resistant group B streptococci, together with genetic mechanisms of resistance and genomic diversity. ermB, ermA, and mefA were found in, respectively, 57, 32, and 9% of isolates. The telithromycin MIC at which 90% of isolates were inhibited was 0.5 micro g/ml. Macrolide resistance was associated with dissemination of resistance determinants among isolates of different genetic backgrounds.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Drug Resistance, Bacterial
  • Erythromycin / pharmacology
  • Female
  • Genes, Bacterial / genetics
  • Humans
  • Infant, Newborn
  • Ketolides*
  • Macrolides / pharmacology*
  • Membrane Proteins / genetics
  • Methyltransferases / genetics
  • Microbial Sensitivity Tests
  • Pregnancy
  • Reverse Transcriptase Polymerase Chain Reaction
  • Streptococcal Infections / microbiology*
  • Streptococcus agalactiae / drug effects*
  • Streptococcus agalactiae / genetics*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Ketolides
  • Macrolides
  • MefA protein, Streptococcus
  • Membrane Proteins
  • Erythromycin
  • Methyltransferases
  • ErmA protein, Bacteria
  • rRNA (adenosine-O-2'-)methyltransferase
  • telithromycin